We do not request reimbursement of costs
(such as repayment for obtaining medical records)
from veterans nor from people who suffer from multiple sclerosis.
Thrombocytosis is a blood disorder that causes the body to produce far more platelets than it needs, and it raises an understandable question for anyone facing a serious diagnosis: can it qualify as a disability? On its own, thrombocytosis is not listed as a specific disability under Social Security Administration (SSA) rules, so a diagnosis alone will not automatically approve a claim. That said, many people with thrombocytosis do go on to qualify for Social Security Disability Insurance (SSDI) or Supplemental Security Income (SSI) when the condition stems from a serious underlying illness or produces complications severe enough to prevent full-time work. Rather than looking at the diagnosis in isolation, the SSA examines how the disorder actually limits a person’s day-to-day functioning. This guide explains what thrombocytosis is, how the SSA reviews these claims, and what evidence can support a successful application for benefits.
Platelets are produced in the bone marrow and play a critical role in stopping bleeding after an injury. A normal platelet count generally falls between 150,000 and 450,000 per microliter of blood. When that number climbs above 450,000, doctors diagnose thrombocytosis, usually after a routine complete blood count reveals the abnormality. There are two main types, and the distinction matters a great deal for a disability claim:
Secondary thrombocytosis often improves once the underlying cause is treated, while primary thrombocythemia tends to require lifelong monitoring and, in some cases, medication to reduce clotting risk.
Many people with mild thrombocytosis have no symptoms at all, and the condition is sometimes discovered incidentally during unrelated bloodwork. As platelet counts rise, however, complications can become serious and even life-threatening. Reported symptoms include:
It’s usually these complications, rather than the elevated platelet count itself, that determine whether someone is unable to sustain full-time work.
Diagnosis typically starts with a routine complete blood count, but when platelet levels are persistently elevated, doctors often order follow-up testing to pinpoint the cause. This can include a JAK2 gene mutation test to check for primary thrombocythemia, iron studies to rule out deficiency-related causes, inflammatory markers, and sometimes a bone marrow biopsy. Treatment depends heavily on the underlying cause: secondary thrombocytosis is usually managed by treating whatever condition triggered it, while primary thrombocythemia may require low-dose aspirin to reduce clotting risk or platelet-lowering medications such as hydroxyurea or anagrelide. Regular monitoring is essential either way, since platelet counts and symptoms can fluctuate significantly over time.
The SSA’s official list of impairments does not include thrombocytosis by name. Instead, blood disorders with clotting or bleeding complications are evaluated under the hematological listings, such as chronic thrombocytopenia or disorders of thrombosis and hemostasis, or under listings for an underlying condition like cancer or an autoimmune disease. That means applicants generally can’t point to a single listing and automatically qualify based on lab values alone. Instead, the SSA looks at the fuller picture, including any underlying condition driving the elevated platelet count, the severity of any complications, and the functional limitations that result from all of it combined.
Because thrombocytosis so often accompanies other diagnosable disorders, reviewers frequently look to the wide range of medical conditions our firm has helped clients pursue benefits for, since a related diagnosis may carry more established disability criteria than thrombocytosis alone.
If your thrombocytosis results from a condition that does appear in the SSA’s listings—certain cancers, autoimmune disorders, or chronic organ dysfunction, for example—your claim may be evaluated under that listing instead of thrombocytosis itself. This is often the fastest path to approval when the medical evidence clearly supports it, since the listings spell out specific clinical findings the SSA accepts as automatically disabling.
Most thrombocytosis claims are ultimately decided through a residual functional capacity (RFC) assessment rather than a listing match. The SSA reviews your medical records, reported symptoms, and the physical or mental demands of your past work to determine what level of work, if any, you can still perform. If your RFC shows you can’t perform your previous job or adjust to other available work considering your age, education, and experience, you may receive a medical-vocational allowance. Understanding how the SSDI program replaces lost income for workers with qualifying impairments can help applicants set realistic expectations before they file.
Because secondary thrombocytosis is often a byproduct of another illness, thoroughly documenting that root cause is essential to a strong claim. Common triggers include:
When one of these conditions is well documented and independently disabling, it can carry significant weight in your case, sometimes more than the thrombocytosis diagnosis itself. A treating physician who can clearly connect the underlying illness to your elevated platelet count and resulting symptoms strengthens the overall record considerably, and it helps the SSA see the claim as a cohesive medical picture rather than a collection of isolated lab values.
A strong claim relies on thorough, consistent documentation built over time rather than a single lab report. Helpful records include:
Gathering the medical documentation needed for a disability benefit claim early in the process can prevent unnecessary delays and reduce the chance of an avoidable denial.
Not every case of thrombocytosis stops someone from working. The condition typically becomes disabling when it produces symptoms that interfere with concentration, physical stamina, or safety on the job. Chronic fatigue, frequent headaches, or numbness in the extremities can make it difficult to perform tasks requiring focus or manual dexterity, while an elevated clotting risk may make physically demanding or safety-sensitive jobs untenable altogether. In more severe cases, individuals experience overlapping symptoms similar to those the SSA weighs in chronic pain disability claims, where fatigue and cognitive fog combine to erode a person’s overall capacity for sustained work.
Applicants sometimes find it helpful to review the conditions that automatically qualify for SSDI to understand how their own diagnosis compares to conditions with more clear-cut approval paths, and our frequently asked questions page addresses many of the practical concerns people raise before filing.
Thrombocytosis claims are rarely straightforward, largely because the SSA has no dedicated listing to evaluate them against. An attorney familiar with hematological and autoimmune disability claims can help identify which underlying conditions to emphasize, gather the right specialist records, and present a residual functional capacity argument that accurately reflects your day-to-day limitations. This kind of guidance often makes the difference between an initial denial and an approved claim, particularly at the hearing stage, where an administrative law judge weighs medical and vocational evidence together before reaching a decision. Applicants weighing their options may also benefit from understanding what conditions qualify for Social Security disability more broadly before deciding how to move forward.
Thrombocytosis by itself is not an automatic disability, but it can support a successful SSDI or SSI claim when it stems from a serious underlying condition or produces complications like clotting, bleeding, or debilitating fatigue that prevent full-time work. Because these claims hinge on connecting your diagnosis to concrete functional limitations, thorough medical documentation and knowledgeable legal guidance make a real difference in the outcome, and starting that documentation early is often the single most useful thing an applicant can do. The team at Chermol & Fishman has helped applicants throughout the region build these kinds of cases, including clients in Feasterville, Southampton, Richboro, and Bucks County, Pennsylvania.
Rarely on its own. The SSA typically wants to see that the elevated platelet count stems from a documented underlying condition or has caused serious complications, such as a blood clot or stroke, that limit your ability to sustain full-time work.
Primary thrombocythemia originates in the bone marrow itself and is usually a lifelong condition. Secondary thrombocytosis is a reaction to another illness, such as an infection or iron deficiency, and often resolves once that underlying issue is treated.
No. Thrombocytosis is not named in the SSA's list of impairments, so most claims are evaluated either under the listing for an underlying condition or through a residual functional capacity assessment.
Consistently elevated complete blood count results over several months, along with hematologist notes documenting symptoms, treatment response, and any complications, provide the strongest foundation for a claim.
Yes. Excess platelets increase clotting risk, and primary thrombocythemia in particular is associated with a higher chance of deep vein thrombosis, pulmonary embolism, and stroke.
The SSA generally requires that a qualifying impairment has lasted, or is expected to last, at least 12 months, or is expected to result in death.
Your claim may be evaluated under the SSA listing for that underlying condition rather than for thrombocytosis, which can make the review process more straightforward if the medical evidence is well documented.
It isn't required, but it's often worthwhile. Because thrombocytosis lacks a dedicated SSA listing, an experienced attorney can help frame the claim around the right underlying condition and functional evidence from the start.